首站-论文投稿智能助手
典型文献
Alpha-fetoprotein,protein induced by vitamin K absence or antagonist-Ⅱ,lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease:A multicenter analysis
文献摘要:
Background:Current surveillance strategies for hepatocellular carcinoma(HCC)among patients with non-alcoholic fatty liver disease(NAFLD)are insufficient.This study aimed to investigate the diagnostic perfor-mance of alpha-fetoprotein(AFP),protein induced by vitamin K absence or antagonist-Ⅱ(PIVKA-Ⅱ),lens culinaris agglutinin-reactive fraction of AFP(AFP-L3),and their combinations in HCC underlying NAFLD patients.Methods:Serologic AFP,AFP-L3,and PIVKA-Ⅱ levels in NAFLD patients with and without HCC were mea-sured.By receiver operating characteristic(ROC)analyses,the area under the curve(AUC),sensitivity,and specificity were obtained to evaluate the diagnostic accuracy of each biomarker and their combinations.Results:This study was conducted on 139 patients with NAFLD-HCC and 345 NAFLD controls.The eleva-tion of these three biomarkers was observed in patients with NAFLD-HCC compared to those in NAFLD controls(all P<0.001).When they were analyzed individually,PIVKA-Ⅱ showed the best performance in diagnosing any-stage HCC with an AUC of 0.869,followed by AFP(0.763;vs.PIVKA-Ⅱ,P<0.001)and AFP-L3(0.689;vs.PIVKA-Ⅱ,P<0.001).When they were analyzed in combination,AFP+PIVKA-Ⅱ yielded the highest AUC(0.906),followed by AFP+PIVKA-Ⅱ+AFP-L3(0.904;vs.AFP+PIVKA-Ⅱ,P=0.086),PIVKA-Ⅱ+AFP-L3(0.881;vs.AFP+PIVKA-Ⅱ,P<0.001),and AFP+AFP-L3(0.759;vs.AFP+PIVKA-Ⅱ,P<0.001).Similar findings were obtained in the subgroup with early-stage NAFLD-HCC,as well as the non-cirrhotic subgroup.Conclusions:These data validated the better diagnostic ability of PIVKA-Ⅱ than AFP or AFP-L3 alone for diagnosing any-stage HCC among patients with NAFLD,and the combination of AFP+PIVKA-Ⅱ signifi-cantly improved the diagnostic accuracy of NAFLD-HCC.
文献关键词:
作者姓名:
Ming-Cheng Guan;Wei Ouyang;Si-Yu Liu;Li-Yang Sun;Wei-Yue Chen;Xiang-Min Tong;Hong Zhu;Tian Yang
作者机构:
Department of Medical Oncology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Department of Laboratory,Zhejiang University Lishui Hospital,Lishui 323000,China;Department of Hepatobiliary,Pancreatic and Minimal Invasive Surgery,Zhejiang Provincial People's Hospital,People's Hospital of Hangzhou Medical College,Hangzhou 310014,China;The Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province,Department of Interventional Radiology,Zhejiang University Lishui Hospital,Lishui 323000,China;School of Clinical Medicine,Hangzhou Medical College,Hangzhou 310059,China;Department of Hepatobiliary Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University(Navy Medical University),Shanghai 200438,China
引用格式:
[1]Ming-Cheng Guan;Wei Ouyang;Si-Yu Liu;Li-Yang Sun;Wei-Yue Chen;Xiang-Min Tong;Hong Zhu;Tian Yang-.Alpha-fetoprotein,protein induced by vitamin K absence or antagonist-Ⅱ,lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease:A multicenter analysis)[J].国际肝胆胰疾病杂志(英文版),2022(06):559-568
A类:
culinaris,Serologic,AFP+PIVKA,+AFP,AFP+AFP
B类:
Alpha,fetoprotein,induced,by,vitamin,absence,antagonist,lens,agglutinin,reactive,fraction,alpha,alone,early,detection,hepatocellular,carcinoma,from,nonalcoholic,fatty,liver,disease,multicenter,analysis,Background,Current,surveillance,strategies,HCC,among,patients,NAFLD,insufficient,This,study,aimed,investigate,diagnostic,L3,their,combinations,underlying,Methods,levels,without,were,mea,sured,By,receiver,operating,characteristic,analyses,area,curve,sensitivity,specificity,obtained,evaluate,accuracy,each,Results,was,conducted,controls,eleva,these,three,biomarkers,observed,compared,those,When,they,analyzed,individually,showed,best,performance,diagnosing,any,stage,followed,yielded,highest,Similar,findings,subgroup,well,cirrhotic,Conclusions,These,data,validated,better,ability,than,signifi,cantly,improved
AB值:
0.384933
相似文献
Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study
Qiang Zhang;Sheng Zhang;Jianxin Li;Yi Pan;Jing Zhao;Yixing Feng;Yanhui Zhao;Xiaoqing Wang;Zhiming Zheng;Xiangming Yang;Lixia Liu;Chunxin Qin;Ke Zhao;Xiaonan Liu;Caixia Li;Liuyang Zhang;Chunrui Yang;Na Zhuo;Hong Zhang;Jie Liu;Jinglei Gao;Xiaoling Di;Fanbo Meng;Wei Ji;Meng Yang;Xiaojie Xin;Xi Wei;Rui Jin;Lun Zhang;Xudong Wang;Fengju Song;Xiangqian Zheng;Ming Gao;Kexin Chen;Xiangchun Li-Department of Maxillofacial and Otorhinolaryngology Oncology;Department of Diagnostic and Therapeutic Ultrasonography;Department of Ultrasonography;Department of Pathology;Department of Ultrasonography,Affiliated Hospital of Chifeng University,Chifeng 024000,China;Department of Ultrasonography,Integrated Traditional Chinese and Western Medicine Hospital of Jilin city Jilin Province,Jilin 132000,China;Department of Ultrasonography,Dezhou Municipal Hospital,Dezhou 253000,China;Department of Ultrasound Room of Functions Branch,Affiliated Hospital of Hebei University,Baoding 071000,China;Department of Thyroid and Breast Surgery,Weihai Municipal Hospital,Cheeloo College of Medicine,Shandong University,Weihai 262400,China;0Department of General Surgery,Tianjin Medical University General Hospital,Tianjin 300000,China;Department of Thyroid and Breast Surgery,Tianjin 4th Centre Hospital,Tianjin 300000,China;Department of Thyroid Surgery,Affiliated Hospital of Chengde Medical University,Chengde 067000,China;Department of Ultrasonography,The Second Hospital of Tianjin Medical University,Tianjin 300000,China;Department of Thyroid,the Second Hospital of Jilin University,Changchun 130041,China;Department of Head and Neck Thyroid Surgery,Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province,Cangzhou 061000,China;Department of Surgery of Glands,People's Hospital of Dingzhou,Dingzhou 073000,China;Department of Thyroid and Breast Surgery,Affiliated Hospital of Shaoxing University,Shaoxing 312000,China;Public Laboratory;Department of Epidemiology and Biostatistics;Department of Thyroid and Neck Cancer,National Clinical Research Center for Cancer,Key Laboratory of Molecular Cancer Epidemiology of Tianjin,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin Medical University Cancer Institute and Hospital,Tianjin Medical University,Tianjin 300060,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases
Xiao Wei;Du Longyi;Cai Linli;Miao Tiwei;Mao Bing;Wen Fuqiang;Gibson Peter Gerard;Gong Deying;Zeng Yan;Kang Mei;Du Xinmiao;Qu Junyan;Wang Yan;Liu Xuemei;Feng Ruizhi;Fu Juanjuan-Respiratory Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Divison of Pulmonary Diseases, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, China;Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW 2305, Australia;Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia;Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW 2305, Australia;Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;Department of Pneumology, Pidu District of Traditional Chinese Medicine, The Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611730, China;Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Center of Infectious Disease, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Research Core Facility, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
Liu Jiaye;Tian Ye;Fu Xia;Mu Chunyang;Yao Menglin;Ni Yinyun;Liu Yong;Li Zhihui-Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610000, China;Respiratory Health Institute, Frontiers Science Center for Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan 610000, China;Department of Outpatients, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Gastroenterological Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
Gui Yinli;Bai Wei;Xu Jian;Duan Xinwang;Zhan Feng;Zhao Chen;Jiang Zhenyu;Li Zhijun;Wu Lijun;Liu Shengyun;Yang Min;Wei Wei;Wang Ziqian;Zhao Jiuliang;Wang Qian;Leng Xiaomei;Tian Xinping;Li Mengtao;Zhao Yan;Zeng Xiaofeng;CSTAR co-authors-Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;Department of Rheumatology, The People’s Hospital of Zhengzhou, Zhengzhou, Henan 450003, China;Department of Rheumatology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China;Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China;Department of Rheumatology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, China;Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;Department of Rheumatology, The Bethune First Hospital of Jilin University, Changchun, Jilin 130021, China;Department of Rheumatology, The Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China;Department of Rheumatology, The People’s Hospital of Xinjiang Autonomous Region, Urumqi, Xinjiang 830001, China;Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Department of Rheumatology, Tianjin Medical University General Hospital, Tianjin 300052, China
A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study
Sun Juxian;Liu Chang;Shi Jie;Wang Nanya;Jiang Dafeng;Mao Feifei;Gu Jingwen;Zhou Liping;Shen Li;Yee Lau Wan;Cheng Shuqun-Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Integrative Oncology, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Outpatient Department, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Oncology, First Hospital of Jilin University, Changchun, Jilin 130000, China;Department of Oncology Zhejiang Sian International Hospital, Jiaxing, Zhejiang 314000, China;Tongji University Cancer Center, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200040, China;Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR 999077, China
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis
Shoubin Zhan;Ping Yang;Shengkai Zhou;Ye Xu;Rui Xu;Gaoli Liang;Chenyu Zhang;Xi Chen;Liuqing Yang;Fangfang Jin;Yanbo Wang-Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy,State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology,Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology,NJU Advanced Institute of Life Sciences(NAILS),School of Life Sciences,Nanjing University,Nanjing 210023,China;Department of Clinical Laboratory,The Affiliated Drum Tower Hospital of Nanjing University Medical School,Nanjing 210023,China;Department of Infectious Diseases,The First People's Hospital of Lianyungang,The First Affiliated Hospital of Kangda College of Nanjing Medical University,Lianyungang 222000,China;School of Medicine&Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。